DEF 14A Filing

Company

Traws Pharma, Inc.

Filed

January 13, 2021

Period of Report

March 4, 2021

Accession Number

0001104659-21-003865

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →